Cohen Klingenstein’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.51M Sell
23,250
-1,460
-6% -$384K 0.19% 60
2026
Q1
$6.59M Hold
24,710
0.21% 54
2025
Q4
$6.2M Hold
24,710
0.19% 58
2025
Q3
$7.09M Hold
24,710
0.22% 53
2025
Q2
$6.49M Hold
24,710
0.22% 57
2025
Q1
$5.75M Hold
24,710
0.21% 62
2024
Q4
$5.67M Sell
24,710
-1,500
-6% -$344K 0.19% 61
2024
Q3
$5.86M Hold
26,210
0.2% 74
2024
Q2
$5.33M Sell
26,210
-69
-0.3% -$14K 0.19% 73
2024
Q1
$5.74M Sell
26,279
-1,422
-5% -$313K 0.21% 71
2023
Q4
$6.3M Hold
27,701
0.26% 63
2023
Q3
$5.57M Sell
27,701
-4,543
-14% -$958K 0.25% 66
2023
Q2
$6.69M Sell
32,244
-1,745
-5% -$339K 0.29% 59
2023
Q1
$6.7M Sell
33,989
-1,397
-4% -$287K 0.31% 60
2022
Q4
$7.16M Hold
35,386
0.36% 52
2022
Q3
$6.23M Hold
35,386
0.33% 56
2022
Q2
$7.13M Hold
35,386
0.36% 57
2022
Q1
$8.02M Hold
35,386
0.33% 55
2021
Q4
$9.55M Sell
35,386
-7,939
-18% -$1.97M 0.38% 48
2021
Q3
$10.5M Sell
43,325
-8,724
-17% -$2.2M 0.46% 42
2021
Q2
$12.3M Sell
52,049
-1,153
-2% -$263K 0.53% 40
2021
Q1
$11.7M Hold
53,202
0.54% 38
2020
Q4
$9.3M Sell
53,202
-465
-0.9% -$80.3K 0.46% 41
2020
Q3
$8.68M Hold
53,667
0.49% 44
2020
Q2
$7.66M Hold
53,667
0.47% 46
2020
Q1
$5.83M Hold
53,667
0.43% 54
2019
Q4
$7.8M Hold
53,667
0.45% 51
2019
Q3
$7.75M Buy
53,667
+6,402
+14% +$934K 0.49% 47
2019
Q2
$7.02M Sell
47,265
-13,535
-22% -$1.89M 0.5% 50
2019
Q1
$7.99M Buy
+60,800
New +$7.49M 0.56% 43

Other funds holding LH

Cohen Klingenstein's LH Position: Q2 2026 in Review

Cohen Klingenstein reduced its Labcorp (LH) stake by 5.9% in Q2 2026, selling an estimated $384K and leaving 23,250 shares worth $6.51M. The position accounts for 0.19% of the portfolio, ranked #60.

Cohen Klingenstein first reported a position in LH in Q1 2019 and has held it in 30 quarters since. The position peaked at $12.3M in Q2 2021. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Cohen Klingenstein held 23,250 shares of Labcorp worth $6.51M as of Q2 2026.
  • Cohen Klingenstein sold 1,460 Labcorp shares in Q2 2026, an estimated $384K.
  • Labcorp made up 0.19% of Cohen Klingenstein's portfolio in Q2 2026, its #60 holding.
  • Cohen Klingenstein first reported a position in Labcorp in Q1 2019 and has held it in 30 quarters since.
  • Cohen Klingenstein's Labcorp position peaked at $12.3M in Q2 2021.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Cohen Klingenstein's 13F filing for Q2 2026, filed 15 Jul 2026.